Award Winning Presentations

Congratulations to our Award Winning Presentations for 2024

Best Oral presentation:

Spatial Transcriptomics Delineates Tumour Heterogeneity in NACT Triple-Negative Breast Cancer

Isobelle Wall1, Jelmar Quist1, Sarah Pinder1, Shiba Irshad1, Cheryl Gillet1, Victoria Seewaldt2, Shankar Subramaniam3, Maddy Parsons1, Anita Grigoriadis1

1King's College London, London, UK, 2City of Hope, Duarte, United States, 3University of California, Los Angeles, United States

 

Best Poster 

Gut microbiota predict efficacy of neoadjuvant systemic therapy in patients with early breast cancer

Kirsty Ross1,2,4, Ben Nichols2, Rodanthi Papadopoulou2, Martin Macleod1, Judith Fraser1, Sophie Barrett1, Katy Teo3, Elizabeth Mallon3, Aula Ammar4, Joanne Edwards4, Jeff Evans1,4, Konstantinos Gerasimidis2, Iain R Macpherson1,4

1Beatson West of Scotland Cancer Centre, Glasgow, Scotland, UK, 2School of Medicine, University of Glasgow, Glasgow, Scotland, UK, 3 Pathology Department, Queen Elizabeth University Hospital, NHS Greater Glasgow & Clyde, Glasgow, Scotland, UK, 4School of Cancer Sciences, University of Glasgow, Glasgow, Scotland, UK

 

Poster Runner ups:

CDK4/6 inhibitors compared to weekly paclitaxel for treatment of ER+/HER2- advanced breast cancer with impending or established visceral crisis: a retrospective study

Roya Behrouzi1, Anne Armstrong1, Sacha Howell1,2

1The Christie NHS Foundation Trust, Manchester, UK, 2Division of Cancer Sciences, The University of Manchester, Manchester, UK

 

Targeting zinc transporters provides a potent treatment for triple negative and tamoxifen-resistant breast cancer preclinical mouse models

Adam Higgins1, Gillian Seaton1, Richard Clarkson1, Kathryn Taylor2

1European Cancer Stem Cell Research Institute, Cardiff University, Cardiff, Wales, UK, 2School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff, Wales, UK

 

Patient Advocate Poster award:

Gut microbiota predict efficacy of neoadjuvant systemic therapy in patients with early breast cancer

Kirsty Ross1,2,4, Ben Nichols2, Rodanthi Papadopoulou2, Martin Macleod1, Judith Fraser1, Sophie Barrett1, Katy Teo3, Elizabeth Mallon3, Aula Ammar4, Joanne Edwards4, Jeff Evans1,4, Konstantinos Gerasimidis2, Iain R Macpherson1,4

1Beatson West of Scotland Cancer Centre, Glasgow, Scotland, UK, 2School of Medicine, University of Glasgow, Glasgow, Scotland, UK, 3 Pathology Department, Queen Elizabeth University Hospital, NHS Greater Glasgow & Clyde, Glasgow, Scotland, UK, 4School of Cancer Sciences, University of Glasgow, Glasgow, Scotland, UK

UKIBCS

Please contact the conference secretariat:
t: 01332 227776
e: ukibcs@kc-jones.co.uk